Identification of human MAb that broadly neutralizes sarbecoviruses unveils a crucial CDRH3 motif May 3, 2022
SPK-001 demonstrates neutralization activity in vitro against SARS-CoV-2 variants of concern April 14, 2022
AAHI receives donation to support development of next-generation vaccine and therapeutic solutions April 12, 2022
Centrin-knockout L. mexicana show immunization promise for New World cutaneous leishmaniasis March 31, 2022